FDA approval of the generic version of Temodal (Temozolomide) must be getting reasonably close by now. A distribution agreement is already in place with Mayne Pharma's USA division. Also some of the 23 generics recently purchased would now have had trial/stability batches manufactured at Boronia to satisfy the FDA requirements to for transfer to the new manufacturing site. I think they need 6 months of stability data before they can submit the application so expect approvals before end of 2015.
Temozolomide is the key one for me to give the share price a real uplift as Mayne Pharma ability to penetrate the market has been given a boost through their recent acquisitions in the USA and the setting up of a new specialised and experienced marketing group.
- Forums
- ASX - By Stock
- IDT
- Price Catalysts
Price Catalysts, page-2
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IDT (ASX) to my watchlist
|
|||||
Last
11.0¢ |
Change
-0.010(8.33%) |
Mkt cap ! $47.28M |
Open | High | Low | Value | Volume |
12.0¢ | 12.0¢ | 11.0¢ | $4.867K | 41.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 449599 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 193631 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 449599 | 0.110 |
5 | 539533 | 0.105 |
1 | 66666 | 0.100 |
1 | 30000 | 0.099 |
2 | 15500 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 193631 | 4 |
0.125 | 188053 | 4 |
0.130 | 166481 | 3 |
0.135 | 447520 | 2 |
0.140 | 228293 | 3 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
IDT (ASX) Chart |